Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

CAR is a useful marker for assessing alopecia areata severity.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.